Feedback / Questions
Pabparna (BB-301) - Benitec BioPharma
https://www.benitec.com/for-investors/news-events/press-releases/detail/137/benitec-biopharma-provides-positive-interim-clinical-study-results-for-bb-301-phase-1b2a-clinical-trial-and-receives-fda-fast-track-designation-for-bb-301
Nov 3, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next